Pulmonary hypertension historical perspective
|
Pulmonary Hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pulmonary hypertension historical perspective On the Web |
|
American Roentgen Ray Society Images of Pulmonary hypertension historical perspective |
|
Risk calculators and risk factors for Pulmonary hypertension historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]
Overview
Pulmonary hypertension was first described by Ernst von Romberg, a German physician, in 1891.
Historical Perspective
- Pulmonary hypertension was first described by Ernst von Romberg, a German physician, in 1891.
- Dresdale investigated the effects of tolzoline in a woman with pulmonary arterial hypertension causing a sudden reduction in pulmonary vascular resistance;
- In 1913, F. C. Arrillaga, assigned syphilitic arteriosclerosis as etiology of PH; changed the name of disease to Ayerza’s Disease.
- In 1929, Werner Forssman demonstrated that it was possible to perform right sided catheterization in humans by performing catheterization on himself.
- In 1951, Dresdale coined the term primary pulmonary hypertension for the first time.
- In the late 1960s there was an epidemic of pulmonary arterial hypertension induced by aminorex which sparked interest on the disease;
- Pulmonary hypertension was first classified into primary and secondary in 1973 during the World Health Organization (WHO) meeting on PH in Geneva, Switzerland;
- Bosentan was approved to treat pulmonary hypertension in 2001, and sildenafil was approved in 2005.[1]
References
- ↑ Barst RJ (2008). "Pulmonary hypertension: past, present and future". Ann Thorac Med. 3 (1): 1–4. doi:10.4103/1817-1737.37832. PMC 2700428. PMID 19561874.